Travoprost Intracameral Implant in Eyes with Glaucoma or Ocular Hypertension: Early Short-Term Real-World Outcomes
Savak Teymoorian, Jasmin Kaur Harvard Eye Associates, Laguna Hills, CA, USACorrespondence: Savak Teymoorian, Harvard Eye Associates, 23961 Calle de la Magdalena, Suite 300, Laguna Hills, California, 92653, USA, Tel +1 949-951-2020, Fax +1 949-356-1660, Email steymoorian@harvardeye.comPurpose: To ass...
Saved in:
Main Authors: | Teymoorian S, Kaur J |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2025-01-01
|
Series: | Clinical Ophthalmology |
Subjects: | |
Online Access: | https://www.dovepress.com/travoprost-intracameral-implant-in-eyes-with-glaucoma-or-ocular-hypert-peer-reviewed-fulltext-article-OPTH |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of intracameral air injection during Ahmed glaucoma valve implantation on hypertensive phase
by: Sunghyun Kim, et al.
Published: (2025-01-01) -
Bimatoprost Intracameral Implant (Durysta®): A New Era in Glaucoma Management Through Sustained-Release Innovation
by: Vagiakis I, et al.
Published: (2025-01-01) -
Outcomes of the Paul Glaucoma Implant in Refractory Secondary Glaucoma
by: Khodeiry MM, et al.
Published: (2025-01-01) -
Serum Oxidative Stress-related Biomarkers in Ocular Hypertension and Glaucoma
by: Mine Esen Baris, et al.
Published: (2024-12-01) -
Effects of Switching to Netarsudil/Latanoprost Fixed Dose Combination from Various Latanoprost Regimens: The Phase 4 MORE Study
by: Bacharach J, et al.
Published: (2025-01-01)